$ARWR ~The Baird summation of their own analysis of the $VIR foray into HBV interdiction. It is clear the power player in this space is JNJ-3989 &amp; the $JNJ (Janssen) combo treatment,  reliant upon the centralized role of Arrowhead’s RNAi TRiM™️ platform contribution, ARO-HBV. https://t.co/OUerDvm0Tp